Together, these observations imply that DLD-1 is a suitable CRC cell model for providing evidence as to whether or not, restoring SOX9 activity has an anti-oncogenic effect and, if so, how this might impact on the activity of the Wnt/ß-catenin signaling pathway. This evidence concerns the gene SOX9 and colorectal carcinoma.